Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from CRDF

Why Is Cardiff Oncology Stock Trading Lower After Colorectal Cancer Data?

As advancements in cancer treatment continue to evolve, the pursuit of more effective therapies for metastatic colorectal cancer remains a critical focus in the pharmaceutical industry. Cardiff Oncology, Inc. (NASDAQ:CRDF) on Tuesday released data from the ongoing CRDF-004 Phase 2 clinical trial evaluating onvansertib in combination with standard-of-care (SoC) in…

Cardiff Oncology Shares Slide Over 26% In Premarket Trading After Mixed Q2

Cardiff Oncology Shares Slide Over 26% In Premarket Trading After Mixed Q2

Following a disappointing second-quarter earnings report, Cardiff Oncology Inc. (NASDAQ:CRDF) experienced a 26.28% drop in its stock value during pre-market trading on Wednesday after reporting mixed Q2 earnings.

The Paranoid Style in Gun Control Politics

The Paranoid Style in Gun Control Politics

Bloomberg's "The Trace" fabricates a conspiracy about amicus brief writers who adhere to Supreme Court Rules

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

3 Falling Stock to Think About Selling Short Right Now

Worries about sky-high inflation, the Federal Reserve’s hawkish stance, and recession prospects have spurred market sell-off lately. Moreover, investors expect increased market volatility as analysts cut down their earnings estimates. Given the uncertain market conditions, fundamentally weak and losing stocks Snap (SNAP), Allegiant Travel (ALGT), and Cardiff Oncology (CRDF) could…

5 Oncology Stocks Wall Street Predicts Will Rally 135% or More

The oncology industry is expected to grow considerably in 2022, driven by the rising occurrence of cancer in the U.S. population. Furthermore, increasing investments by biopharmaceutical companies and the government should fuel the industry's growth. Given the industry's bright growth prospects, Wall Street analysts expect the stocks of quality oncology…

Cardiff Oncology: Q4 Earnings Insights

Cardiff Oncology (NASDAQ:CRDF) reported its Q4 earnings results on Thursday, February 24, 2022 at 04:10 PM. Here's what investors need to know about the announcement.

Cardiff Oncology Slumps On New Data From Lead Program In Metastatic Colorectal Cancer

Cardiff Oncology Inc (NASDAQ: CRDF) posted

inkl

Read news from The Economist, FT, and more,
with one subscription

1

People

Mangeet Kaur BounsMangeet

Sheldon Whitehouse

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

US Federal Reserve

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play